InvestorsHub Logo
Followers 17
Posts 840
Boards Moderated 0
Alias Born 04/05/2014

Re: None

Monday, 05/11/2020 10:13:21 AM

Monday, May 11, 2020 10:13:21 AM

Post# of 144813
And yet another PR out today with yet another hurdle that was completed and, of course, with yet another hurdle to be completed still. It is continuous. The investors in the street gave it their wink, whereas the PPS goes down further. These nonsense PRs that only state we aren't done when we once said we were done isn't cutting it in the real world. It is all subterfuge. It is all fake. It is all a scam. What is next? Read between the lines. - Waggoner, said, “We continue to work through a checklist of items that are necessary to submit an acceptable Investigational New Drug application (IND) to the FDA. The work that cGMP Validation and Austrianova are currently performing to audit the manufacturing facility in Thailand and the work they have completed working together to make certain the batch records meet the cGMP requirements for manufacturing a clinical trial product was and continues to be incredibly detailed and must continue to follow strict FDA guidelines.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News